139 related articles for article (PubMed ID: 7954356)
1. Arsenic-related Bowen's disease and paraquat-related skin cancerous lesions show no detectable ras and p53 gene alterations.
Hsieh LL; Chen HJ; Hsieh JT; Jee SH; Chen GS; Chen CJ
Cancer Lett; 1994 Oct; 86(1):59-65. PubMed ID: 7954356
[TBL] [Abstract][Full Text] [Related]
2. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 promoter -56 and -54bp CpG un-methylation predicts invasive progression in arsenic-induced Bowen's disease.
Liao WT; You HL; Chai CY; Lee CH; Lan CE; Chang SJ; Yu CL; Yu HS
J Dermatol Sci; 2018 Feb; 89(2):191-197. PubMed ID: 29103775
[TBL] [Abstract][Full Text] [Related]
4. Ureteral tumor with multiple Bowen's disease forty-two years after exposure to arsenic.
Koh E; Kondoh N; Kaihara H; Fujioka H; Kitamura K
Eur Urol; 1989; 16(5):398-400. PubMed ID: 2776813
[TBL] [Abstract][Full Text] [Related]
5. Bowen's disease of the plantar arch.
Allen RB; Richardson DR; Futrell JW
Cutis; 1979 Jun; 23(6):805-7. PubMed ID: 467101
[TBL] [Abstract][Full Text] [Related]
6. The role of oxidative DNA damage in human arsenic carcinogenesis: detection of 8-hydroxy-2'-deoxyguanosine in arsenic-related Bowen's disease.
Matsui M; Nishigori C; Toyokuni S; Takada J; Akaboshi M; Ishikawa M; Imamura S; Miyachi Y
J Invest Dermatol; 1999 Jul; 113(1):26-31. PubMed ID: 10417614
[TBL] [Abstract][Full Text] [Related]
7. p53 mutation spectrum in Japanese Bowen's disease suggests a role for mutagens other than ultraviolet light.
Takata M; Rehman I; Rees JL
Int J Cancer; 1997 May; 71(3):370-2. PubMed ID: 9139870
[TBL] [Abstract][Full Text] [Related]
8. Multiple Bowen's disease associated with squamous cell carcinoma--a report of a case.
Ismail R; Cheng PS
J Dermatol; 1988 Feb; 15(1):65-7. PubMed ID: 2969012
[No Abstract] [Full Text] [Related]
9. Arsenic-induced keratoses and Bowen's disease.
Watson K; Creamer D
Clin Exp Dermatol; 2004 Jan; 29(1):46-8. PubMed ID: 14723721
[TBL] [Abstract][Full Text] [Related]
10. Codon 12 Harvey-ras mutations are rare events in non-melanoma human skin cancer.
Campbell C; Quinn AG; Rees JL
Br J Dermatol; 1993 Feb; 128(2):111-4. PubMed ID: 8096149
[TBL] [Abstract][Full Text] [Related]
11. Significance of mitotic cells or clumping cells in p53 immunopositivity of Bowen's disease.
Ura H; Nashiro K; Kikuchi K; Imakado S; Matsukawa A; Furue M
Dermatology; 1997; 194(1):87-8. PubMed ID: 9031804
[No Abstract] [Full Text] [Related]
12. Involvement of mtDNA damage elicited by oxidative stress in the arsenical skin cancers.
Lee CH; Wu SB; Hong CH; Chen GS; Wei YH; Yu HS
J Invest Dermatol; 2013 Jul; 133(7):1890-900. PubMed ID: 23370535
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous and induced sister chromatid exchanges and delayed cell proliferation in peripheral lymphocytes of Bowen's disease patients and matched controls of arseniasis-hyperendemic villages in Taiwan.
Hsu YH; Li SY; Chiou HY; Yeh PM; Liou JC; Hsueh YM; Chang SH; Chen CJ
Mutat Res; 1997 Jun; 386(3):241-51. PubMed ID: 9219562
[TBL] [Abstract][Full Text] [Related]
14. Merkel cell carcinoma, Bowen's disease and chronic occupational arsenic poisoning.
Tsuruta D; Hamada T; Mochida K; Nakagawa K; Kobayashi H; Ishii M
Br J Dermatol; 1998 Aug; 139(2):291-4. PubMed ID: 9767246
[TBL] [Abstract][Full Text] [Related]
15. Arsenical cancer of skin. Histologic study with special reference to Bowen's disease.
Yeh S; How SW; Lin CS
Cancer; 1968 Feb; 21(2):312-39. PubMed ID: 4952508
[No Abstract] [Full Text] [Related]
16. Mitochondrial biogenesis drives tumor cell proliferation.
Martinez-Outschoorn UE; Pavlides S; Sotgia F; Lisanti MP
Am J Pathol; 2011 May; 178(5):1949-52. PubMed ID: 21514412
[TBL] [Abstract][Full Text] [Related]
17. Merkel cell carcinoma and multiple Bowen's disease: incidental association or possible relationship to inorganic arsenic exposure?
Ohnishi Y; Murakami S; Ohtsuka H; Miyauchi S; Shinmori H; Hashimoto K
J Dermatol; 1997 May; 24(5):310-6. PubMed ID: 9198320
[TBL] [Abstract][Full Text] [Related]
18. Multiple Bowen's diseases and basal cell carcinomas in a patient with acute promyelocytic leukemia treated with arsenic trioxide: A case report and effective treatment with photodynamic therapy.
Ding C; Ma YY; Wang P; Liu J
Dermatol Ther; 2018 Nov; 31(6):e12718. PubMed ID: 30239071
[TBL] [Abstract][Full Text] [Related]
19. Arsenic exposure followed by the development of dermatofibrosarcoma protuberans.
Shneidman D; Belizaire R
Cancer; 1986 Oct; 58(7):1585-7. PubMed ID: 3742477
[TBL] [Abstract][Full Text] [Related]
20. Bowen's disease in blacks.
Rosen T; Tucker SB; Tschen J
J Am Acad Dermatol; 1982 Sep; 7(3):364-8. PubMed ID: 7130498
[No Abstract] [Full Text] [Related]
[Next] [New Search]
